1 Min Read
June 13 (Reuters) - IMMUNOVIA AB (PUBL):
* IMMUNOVIA‘S BIOMARKER SIGNATURE FOR DIAGNOSIS OF PANCREATIC CANCER NOW PATENTED IN JAPAN Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.